Skip to main content
TipRanks
Go Ultimate75% OFF

Samyang Biopharm Corporation (0120G0) Ownership - Who Owns Samyang Biopharm Corporation?

Samyang Biopharm Corporation (0120G0) Ownership Overview

  • 2.00% Mutual Funds
  • 1.87% ETFs
  • 96.13% Public Companies and Individual Investors

The ownership structure of Samyang Biopharm Corporation (KR:0120G0) stock is a mix of institutional, retail, and individual investors. Approximately 3.87% of the company’s stock is owned by Institutional Investors, and 96.13% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

KR:0120G0 top shareholders
Holder# of SharesType% HoldingValue
Vanguard116,783Institution1.57%3,474,528
Vanguard Star Funds53,128Institution0.71%1,580,664
Vanguard Tax-managed Funds41,555Institution0.56%1,236,344
Dfa Investment Dimensions Group Inc28,940Institution0.39%861,023
Vanguard International Equity Index Funds22,927Institution0.31%682,124
Dimensional9,298Institution0.13%276,634
State Street5,838Institution0.08%173,692
Schwab4,926Institution0.07%146,558
Schwab Capital Trust2,326Institution0.03%69,203
Avantis1,759Institution0.02%52,334

Top Mutual Fund Holders

KR:0120G0 top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Star Funds53,128Institution0.71%1,580,664
Vanguard Tax-managed Funds41,555Institution0.56%1,236,344
Dfa Investment Dimensions Group Inc28,940Institution0.39%861,023
Vanguard International Equity Index Funds22,927Institution0.31%682,124
Schwab Capital Trust2,326Institution0.03%69,203
American Century Etf Trust187Institution<0.01%5,564

Top ETF Holders

KR:0120G0 top ETF holders
Holder# of SharesType% HoldingValue
Vanguard Total International Stock ETF, VXUS ETF53,128Institution0.71%1,510,780
Vanguard FTSE Developed Markets ETF, VEA ETF41,555Institution0.56%1,181,682
Vanguard FTSE All-World ex-US Small-Cap ETF, VSS ETF13,510Institution0.18%460,556
SPDR S&P International Small Cap ETF, GWX ETF5,838Institution0.08%175,671
Schwab Fundamental International Small Co. Index ETF, FNDC ETF4,926Institution0.07%148,228
Vanguard FTSE Pacific ETF, VPL ETF4,772Institution0.06%135,699
Dimensional Emerging Markets Core Equity 2 ETF, DFEM ETF4,733Institution0.06%142,420
Dimensional World ex U.S. Core Equity 2 ETF, DFAX ETF3,700Institution0.05%111,337
Vanguard Total World Stock ETF, VT ETF2,810Institution0.04%79,907
Avantis Emerging Markets Equity ETF, AVEM ETF1,753Institution0.02%51,738

FAQ

What percentage of Samyang Biopharm Corporation (KR:0120G0) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.87% of Samyang Biopharm Corporation (KR:0120G0) stock is held by institutional investors: 2.00% by mutual funds and 1.87% by ETFs.
What percentage of Samyang Biopharm Corporation (KR:0120G0) stock is held by retail investors?
According to the latest TipRanks data, approximately 96.13% of Samyang Biopharm Corporation (KR:0120G0) stock is held by public companies and individual investors.
Who owns the most shares of Samyang Biopharm Corporation (KR:0120G0)?
Vanguard owns the most shares of Samyang Biopharm Corporation (KR:0120G0).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.